These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 23544717)

  • 21. Symptomatic therapy of multiple sclerosis.
    Markowitz C
    Continuum (Minneap Minn); 2010 Oct; 16(5 Multiple Sclerosis):90-104. PubMed ID: 22810600
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Challenges to clinical trials in multiple sclerosis: outcome measures in the era of disease-modifying drugs.
    Hyland M; Rudick RA
    Curr Opin Neurol; 2011 Jun; 24(3):255-61. PubMed ID: 21455068
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current and future disease-modifying therapies in multiple sclerosis.
    Lim SY; Constantinescu CS
    Int J Clin Pract; 2010 Apr; 64(5):637-50. PubMed ID: 20456216
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple sclerosis- diagnosis, management and prognosis.
    Tsang BK; Macdonell R
    Aust Fam Physician; 2011 Dec; 40(12):948-55. PubMed ID: 22146321
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The management of pediatric multiple sclerosis.
    Yeh EA; Weinstock-Guttman B
    J Child Neurol; 2012 Nov; 27(11):1384-93. PubMed ID: 22914373
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiple sclerosis spasticity: 'state-of-the-art' questionnaire survey of specialized healthcare professionals.
    Collongues N; Vermersch P
    Expert Rev Neurother; 2013 Feb; 13(3 Suppl 1):21-5. PubMed ID: 23369056
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New drug therapies for multiple sclerosis.
    Mangas A; Coveñas R; Geffard M
    Curr Opin Neurol; 2010 Jun; 23(3):287-92. PubMed ID: 20414110
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improving quality of life in multiple sclerosis: an unmet need.
    Zwibel HL; Smrtka J
    Am J Manag Care; 2011 May; 17 Suppl 5 Improving():S139-45. PubMed ID: 21761952
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment effects of immunomodulatory therapies at different stages of multiple sclerosis in short-term trials.
    Bates D
    Neurology; 2011 Jan; 76(1 Suppl 1):S14-25. PubMed ID: 21205678
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Symptomatic therapy and neurorehabilitation in multiple sclerosis.
    Kesselring J; Beer S
    Lancet Neurol; 2005 Oct; 4(10):643-52. PubMed ID: 16168933
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasticity of the motor system in multiple sclerosis.
    Zeller D; Classen J
    Neuroscience; 2014 Dec; 283():222-30. PubMed ID: 24881573
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current pharmacologic treatment of multiple sclerosis symptoms.
    Andersson PB; Goodkin DE
    West J Med; 1996 Nov; 165(5):313-7. PubMed ID: 8993211
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Current treatment of multiple sclerosis].
    Csépány T
    Lege Artis Med; 2011 Feb; 21(2):97-104. PubMed ID: 21710707
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pregnancy and multiple sclerosis.
    Houtchens MK
    Semin Neurol; 2007 Nov; 27(5):434-41. PubMed ID: 17940922
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of multiple sclerosis: current trials and future options.
    Noseworthy JH
    Curr Opin Neurol; 2003 Jun; 16(3):289-97. PubMed ID: 12858064
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Natalizumab treatment in pediatric multiple sclerosis: a case report.
    Borriello G; Prosperini L; Luchetti A; Pozzilli C
    Eur J Paediatr Neurol; 2009 Jan; 13(1):67-71. PubMed ID: 18406645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current disease-modifying treatment of multiple sclerosis.
    Derwenskus J
    Mt Sinai J Med; 2011; 78(2):161-75. PubMed ID: 21425262
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Immunomodulatory therapy in multiple sclerosis].
    Csépány T; Bereczki D
    Ideggyogy Sz; 2004 Nov; 57(11-12):401-16. PubMed ID: 15662768
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management options in multiple sclerosis-associated fatigue.
    Amato MP; Portaccio E
    Expert Opin Pharmacother; 2012 Feb; 13(2):207-16. PubMed ID: 22220738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Your client has multiple sclerosis: understanding the challenge.
    Turkoski B
    Orthop Nurs; 2013; 32(1):45-50; quiz 51-2. PubMed ID: 23344490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.